Cogane produces encouraging results in MND Association-funded study
Reading Time: 2 minutes Thanks to funding and some strategic ‘match-making’ by the MND Association, a new drug may have taken one step closer to beginning clinical trials in MND after producing promising results in an animal model of the disease. The drug, known as Cogane, was developed by the biotechnology company Phytopharm. It had already demonstrated in laboratory…